Cold Atmospheric Plasma Changes the Amino Acid Composition of Solutions and Influences the Anti-Tumor Effect on Melanoma Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Jul 2021
Historique:
received: 11 06 2021
revised: 09 07 2021
accepted: 15 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 17 8 2021
Statut: epublish

Résumé

Cold Atmospheric Plasma (CAP) is an ionized gas near room temperature. Its anti-tumor effect can be transmitted either by direct treatment or mediated by a plasma-treated solution (PTS), such as treated standard cell culture medium, which contains different amino acids, inorganic salts, vitamins and other substances. Despite extensive research, the active components in PTS and its molecular or cellular mechanisms are not yet fully understood. The purpose of this study was the measurement of the reactive species in PTS and their effect on tumor cells using different plasma modes and treatment durations. The PTS analysis yielded mode- and dose-dependent differences in the production of reactive oxygen and nitrogen species (RONS), and in the decomposition and modification of the amino acids Tyrosine (Tyr) and Tryptophan (Trp). The Trp metabolites Formylkynurenine (FKyn) and Kynurenine (Kyn) were produced in PTS with the 4 kHz (oxygen) mode, inducing apoptosis in Mel Im melanoma cells. Nitrated derivatives of Trp and Tyr were formed in the 8 kHz (nitrogen) mode, elevating the p16 mRNA expression and senescence-associated ß-Galactosidase staining. In conclusion, the plasma mode has a strong impact on the composition of the active components in PTS and affects its anti-tumor mechanism. These findings are of decisive importance for the development of plasma devices and the effectiveness of tumor treatment.

Identifiants

pubmed: 34360651
pii: ijms22157886
doi: 10.3390/ijms22157886
pmc: PMC8346059
pii:
doi:

Substances chimiques

CDKN2A protein, human 0
Cyclin-Dependent Kinase Inhibitor p16 0
Plasma Gases 0
Reactive Nitrogen Species 0
Reactive Oxygen Species 0
Tyrosine 42HK56048U
Tryptophan 8DUH1N11BX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Mutat Res. 2013 Apr 30;753(1):23-8
pubmed: 23416235
PLoS One. 2014 Jul 28;9(7):e103349
pubmed: 25068311
Sci Rep. 2014 Dec 23;4:7589
pubmed: 25534001
Free Radic Res. 2014 May;48(5):542-9
pubmed: 24528134
J Dtsch Dermatol Ges. 2018 Jan;16(1):7-13
pubmed: 29211323
J Am Chem Soc. 1967 Feb 15;89(4):1017-21
pubmed: 6037015
Pol J Microbiol. 2019;68(2):153-164
pubmed: 31250588
Biol Chem. 2018 Dec 19;400(1):39-62
pubmed: 30044757
Oncotarget. 2017 Feb 28;8(9):15977-15995
pubmed: 27845910
Int J Cancer. 2012 Apr 15;130(8):1715-25
pubmed: 22025288
PLoS One. 2011;6(11):e28154
pubmed: 22140530
Sci Rep. 2020 Aug 12;10(1):13580
pubmed: 32788628
Sci Rep. 2016 May 13;6:26016
pubmed: 27172875
Sci Rep. 2019 Apr 29;9(1):6625
pubmed: 31036847
Int J Mol Med. 2014 Oct;34(4):941-6
pubmed: 25050490
Environ Mol Mutagen. 2017 Apr;58(3):172-177
pubmed: 28370324
Appl Environ Microbiol. 2018 Aug 17;84(17):
pubmed: 29915117
Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
Arch Biochem Biophys. 2014 Mar 1;545:133-40
pubmed: 24486404
Mutat Res Genet Toxicol Environ Mutagen. 2016 Mar;798-799:48-54
pubmed: 26994493
Sci Rep. 2019 Mar 11;9(1):4099
pubmed: 30858524
Cancers (Basel). 2019 May 14;11(5):
pubmed: 31091795
Sci Rep. 2018 May 16;8(1):7689
pubmed: 29769707
Biointerphases. 2020 Nov 25;15(6):061008
pubmed: 33238712
Mol Biol Cell. 2014 May;25(9):1523-31
pubmed: 24574456
Sci Rep. 2017 Jul 4;7(1):4562
pubmed: 28676723
PLoS One. 2016 Sep 01;11(9):e0160667
pubmed: 27584003
Future Oncol. 2019 Feb;15(5):495-505
pubmed: 30648877
Anal Chem. 2018 Nov 20;90(22):13151-13158
pubmed: 30289686
Sci Rep. 2017 Feb 22;7:43081
pubmed: 28225083
In Vivo. 2015 Sep-Oct;29(5):611-6
pubmed: 26359422
Sci Rep. 2017 Aug 16;7(1):8319
pubmed: 28814809
Free Radic Biol Med. 2015 Feb;79:28-44
pubmed: 25433364
Sci Rep. 2019 Oct 2;9(1):14210
pubmed: 31578342
Exp Dermatol. 2013 Apr;22(4):284-9
pubmed: 23528215
J Craniomaxillofac Surg. 2016 Sep;44(9):1445-52
pubmed: 27499516
Pathol Int. 2018 Jan;68(1):23-30
pubmed: 29235204
Anticancer Agents Med Chem. 2018;18(6):769-775
pubmed: 28762318
Electrophoresis. 2013 Oct;34(19):2836-47
pubmed: 23857076
J Eur Acad Dermatol Venereol. 2011 Jan;25(1):1-11
pubmed: 20497290
Cancers (Basel). 2019 Sep 01;11(9):
pubmed: 31480642
Int J Mol Sci. 2021 Apr 04;22(7):
pubmed: 33916572
Anticancer Agents Med Chem. 2018;18(6):784-804
pubmed: 28762315
Biomolecules. 2021 Jun 17;11(6):
pubmed: 34204360
Arch Biochem Biophys. 2016 Sep 1;605:102-8
pubmed: 26820218
Biophys J. 2017 Jun 6;112(11):2397-2407
pubmed: 28591612
J Dermatol Sci. 2018 Feb;89(2):181-190
pubmed: 29191392
Sci Rep. 2016 Jul 01;6:29098
pubmed: 27364563
Br J Cancer. 2011 Oct 25;105(9):1295-301
pubmed: 21979421
Exp Eye Res. 2006 Dec;83(6):1439-45
pubmed: 16963024
J Clin Oncol. 1998 Mar;16(3):1197-206
pubmed: 9508208
Free Radic Biol Med. 2020 Nov 20;160:696-718
pubmed: 32911085
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
Biol Chem. 2018 Dec 19;400(1):111-122
pubmed: 29908123
Sci Rep. 2020 Feb 25;10(1):3396
pubmed: 32099012
ACS Appl Mater Interfaces. 2020 Aug 5;12(31):34548-34563
pubmed: 32648738
Cancers (Basel). 2020 Mar 19;12(3):
pubmed: 32204401
Exp Eye Res. 2002 Aug;75(2):165-75
pubmed: 12137762
BMC Bioinformatics. 2010 Jul 23;11:395
pubmed: 20650010
Int J Cancer. 1995 Mar 3;60(5):668-75
pubmed: 7532159
Sci Rep. 2016 Feb 22;6:21421
pubmed: 26898904

Auteurs

Stephanie Arndt (S)

Department of Dermatology, University Medical Center Regensburg, Franz-Josef-Strauss Allee 11, D-93053 Regensburg, Germany.

Fadi Fadil (F)

Institute of Functional Genomics, University of Regensburg, Am BioPark 9, D-93053 Regensburg, Germany.

Katja Dettmer (K)

Institute of Functional Genomics, University of Regensburg, Am BioPark 9, D-93053 Regensburg, Germany.

Petra Unger (P)

Department of Dermatology, University Medical Center Regensburg, Franz-Josef-Strauss Allee 11, D-93053 Regensburg, Germany.

Marko Boskovic (M)

Institute of Functional Genomics, University of Regensburg, Am BioPark 9, D-93053 Regensburg, Germany.

Claudia Samol (C)

Institute of Functional Genomics, University of Regensburg, Am BioPark 9, D-93053 Regensburg, Germany.

Anja-Katrin Bosserhoff (AK)

Institute of Biochemistry, University of Erlangen-Nuernberg, D-91054 Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), D-91054 Erlangen, Germany.

Julia L Zimmermann (JL)

Terraplasma GmbH, D-85748 Garching, Germany.

Michael Gruber (M)

Department of Anesthesiology, University Medical Center Regensburg, Regensburg, Franz-Josef-Strauss Allee 11, D-93053 Regensburg, Germany.

Wolfram Gronwald (W)

Institute of Functional Genomics, University of Regensburg, Am BioPark 9, D-93053 Regensburg, Germany.

Sigrid Karrer (S)

Department of Dermatology, University Medical Center Regensburg, Franz-Josef-Strauss Allee 11, D-93053 Regensburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH